MyndTec Inc. Announces Non-Brokered Private Placement
Mississauga, Ontario--(Newsfile Corp. - November 9, 2022) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging leader in neurological treatment and rehabilitation, is pleased to announce that it has launched a non-brokered private placement of up to 1,333,333 units of the Company (the "Units") at a price of $0.75 per Unit (the "Issue Price") to raise aggregate gross proceeds to the Company of up to $1,000,000 (the "Offering"). The Company has an option (the "Company Option"),...
2022-11-09 8:00 AM EST
MyndTec Announces the North American Launch of its Innovative Foot Drop FES Device MyndStep(TM)
Mississauga, Ontario--(Newsfile Corp. - November 2, 2022) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging leader in neurological rehabilitation, is pleased to announce the launch of its newest product, MyndStepTM, to its functional electrical stimulation (FES) portfolio. The launch of MyndStepTM will focus on leveraging MyndTec's expert capabilities in FES to pursue opportunities in the Medical Device and...
2022-11-02 8:00 AM EDT
MyndTec Announces Exclusive Supply and Distribution Agreement for Innovative Foot Drop FES Device MyndStep(TM) Across the US and Canada
MyndTec expands its FES portfolio with new productMyndStepTM is intended to address foot drop ailments and improve gaitExclusive Supply and Distribution agreement for the United States and CanadaMississauga, Ontario--(Newsfile Corp. - August 5, 2022) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging leader in neurological rehabilitation, is pleased to announce the addition of its newest product MyndStepTM, to its FES portfolio. MyndStepTM addresses foot drop ailments....
2022-08-05 9:20 AM EDT
MyndTec Announces Board Changes
Mississauga, Ontario--(Newsfile Corp. - May 11, 2022) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging leader in neurological rehabilitation, is pleased to announce the appointment of William (Bill) Jackson to its Board as an independent Director and as Chairman of the Board's Audit Committee effective May 11, 2022.With more than 25 years of experience in the medical device industry, Mr. Jackson brings a wealth of entrepreneurial and c-suite experience in building, growing...
2022-05-11 5:43 PM EDT
MyndTec Announces Investor Relations Agreement with Venture North Capital
Mississauga, Ontario--(Newsfile Corp. - May 3, 2022) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging leader in neurological rehabilitation, is pleased to announce that it has entered into a consulting agreement (the "Consulting Agreement") with Venture North Capital Inc. ("Venture North") to provide strategic marketing, investor relations and capital markets communications services to the Company in compliance with the policies and guidelines of the Canadian Securities...
2022-05-03 8:44 PM EDT
Fourier Intelligence Inks Strategic Alliance Partnership with MyndTec Inc.
Singapore, Singapore--(Newsfile Corp. - March 22, 2022) - Fourier Intelligence has announced a strategic alliance partnership with MyndTec Inc., an award-winning Canadian medical technology company specialising in innovative therapeutic medical devices. This partnership will focus on the distribution of MyndMove™, a non-invasive functional electrical stimulation-based intervention, to the ever-expanding global network of Fourier Intelligence. A virtual signing ceremony was held to commemorate...
2022-03-22 5:00 PM EDT
MyndTec Announces Resignation of Director
Mississauga, Ontario--(Newsfile Corp. - March 8, 2022) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging trailblazer in neurological rehabilitation, today announced that Christine Ozimek has tendered her resignation as a director of the Company and Chair of the board of directors of the Company (the "Board") effective March 31, 2022."On behalf the Company, I would like to thank Christine for her contributions to the Company over almost 10 years of service and we wish her...
2022-03-08 9:16 AM EST
MyndTec Receives FDA 510(k) Clearance for MyndMove 2.0, its Second Generation Neuromodulation Device, for Clinical and Home Use
Mississauga, Ontario--(Newsfile Corp. - March 8, 2022) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"), an emerging trailblazer in neurological rehabilitation, today announced that it has received from the U.S. Food and Drug Administration (the "FDA") 510(k) clearance for MyndMove 2.0, its second generation neuromodulation MyndMove System. "This is a very exciting time for the Company as we advance into the strategic re-launch of MyndMove devices in the United States through our...
2022-03-08 7:00 AM EST
MyndTec Inc. Announces Closing of Distribution of Securities Issuable upon Conversion of Subscription Receipts and Listing on CSE
Mississauga, Ontario--(Newsfile Corp. - February 24, 2022) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company") is pleased to announce that, in connection with its filed and receipted final non-offering prospectus dated February 11, 2022 (the "Prospectus"), as of the date hereof, it has closed the distribution of securities (the "Qualifying Securities") issuable upon the conversion of 2,954,302 subscription receipts (the "Subscription Receipts") (the "Distribution"). The Company previously...
2022-02-24 7:00 AM EST
MyndTec Inc. Files Final Prospectus and Receives Conditional Listing Approval from the Canadian Securities Exchange
Mississauga, Ontario--(Newsfile Corp. - February 16, 2022) - MyndTec Inc. ("MyndTec" or the "Company") is pleased to announce that it has filed and received a receipt for its final non-offering prospectus (the "Prospectus") from the Ontario Securities Commission. The Prospectus has been filed under Multilateral Instrument 11-202 - Passport System in Alberta and British Columbia, and therefore a receipt for the Prospectus is deemed to also be issued by the regulator in each of those...
2022-02-16 3:11 PM EST